Product Information
HYSINGLA ER 40 MG TABLET is a brand product labeled by Purdue Pharma LP, priced at $26.1883 per EA under NDC 59011027360. Its NADAC has been published 589 times since Mar 18, 2015.
Strength
40 mg/1
Manufacturer
Purdue Pharma LPNDC
59011027360
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA206627On Market Since
1/15/2015
Pharmacological Classes
Price Statistics
The NADAC for HYSINGLA ER 40 MG TABLET has been published 589 times since Mar 18, 2015, and over the history we have for it it has risen 107.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.1883 per EA |
|---|---|
| All-time high | $26.1883 (Jun 24, 2026) |
| All-time low | $12.4454 (Apr 22, 2015) |
| 52-week high | $26.1883 |
| 52-week low | $24.0247 |
| Median price | $18.7067 |
| Average price | $18.8141 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 589 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hydrocodone bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HYSINGLA ER 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYSINGLA ER 40 MG TABLET, manufactured by Purdue Pharma LP, is $26.1883 per EA (NDC 59011027360), effective Jun 24, 2026.
How has the price of HYSINGLA ER 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYSINGLA ER 40 MG TABLET has risen 107.3%. It has been tracked across 589 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for HYSINGLA ER 40 MG TABLET?
Since Mar 18, 2015, the NADAC for HYSINGLA ER 40 MG TABLET has ranged from a low of $12.4454 (Apr 22, 2015) to a high of $26.1883 (Jun 24, 2026), with a median of $18.7067 per EA.
Are there cheaper alternatives to HYSINGLA ER 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYSINGLA ER 40 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures HYSINGLA ER 40 MG TABLET?
HYSINGLA ER 40 MG TABLET (NDC 59011027360) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.
Related Drugs
Same classification